[1]
C. S. Purbandini and R. Sauriasari, “COST-EFFECTIVENESS ANALYSIS OF CEFTRIAXONE AND NON-CEFTRIAXONE ON TYPHOID FEVER PATIENTS”, Int J App Pharm, vol. 10, no. 1, pp. 87–91, Dec. 2018.